RxDoctor Payments Data

Alexios Apazidis, MD

Orthopaedic Surgery of the Spine · Saint Albans, NYNPI 1245494368

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,741 of the $6,505 with a category attached, or 72.9%. 21 manufacturers reported payments, led by Life Spine, Inc. at 31.3% of the total. Reporting peaked in 2022 at $1,849 and has fallen 95.3% since, to $88 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in NY, where the typical reported total is $11,594.

$6,505in general payments, 2019–2025

Across 71 payments — averaging $91.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Life Spine, Inc.$2K
  • Spinal Elements, Inc.$905
  • Smith+Nephew$621
  • Johnson & Johnson$504
  • DJO, LLC$362
  • Intrinsic Therapeutics$356
  • plus $2K from 15 others
$1,200in research payments, 2019–2025

Across 1 payment — averaging $1200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mitsubishi Tanabe Pharma Development America, Inc.$1K

What the payments were for

  • Consulting fees$1,76427%
  • Food & beverage$4,74173%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,505 in reported general payments places this provider in the 40th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York →

Medicare billing

Part B allowed, 2024
$2,544
Medicare patients
11
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl18$94

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Saint Albans

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →